Academic literature on the topic 'Buccal tablet'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Buccal tablet.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Buccal tablet"

1

Rachana, Sarawade1 Deepak Rathod2. "Formulation And Evaluation of Novel Drug Delivery System Containing Anti Parkinson's Agent." International Journal of Pharmaceutical Sciences 2, no. 12 (2024): 1530–55. https://doi.org/10.5281/zenodo.14406680.

Full text
Abstract:
Introduction : This study explores the use of buccal administration as a potential route for delivering Levodopa (LD) in the treatment of Parkinson's disease (PD). Parkinson's disease is a neurodegenerative disease that affects dopaminergic neurons, leading to a deficiency of dopamine. The current treatment of choice is levodopa, but it has low oral bioavailability and poor brain uptake. The methodology involves the formulation of buccal mucoadhesive tablets that attach to the buccal mucosa. The study highlights the advantages of the formulation by increasing bioavailability and bypassing of g
APA, Harvard, Vancouver, ISO, and other styles
2

Gawai, Nitin, and Zahid Zaheer. "FORMUALTION AND DEVELOPMENT OF MUCOADHESIVE SUSTAINED RELEASE BUCCAL TABLETS AND PATCHES OF 5-FLUOROURACIL USING DIFFERENT POLYMERS." Asian Journal of Pharmaceutical and Clinical Research 11, no. 5 (2018): 174. http://dx.doi.org/10.22159/ajpcr.2018.v11i5.20241.

Full text
Abstract:
Objective: The present research study was undertaken to formulate mucoadhesive sustained release buccal tablets and patches of 5-fluorouracil (5-FU).Method: For the research experiment work design expert software version 10, stat-ease, Inc. has been used. A 32 full factorial design was selected for the formulation of the buccal tablet as well as buccal patches. In this research work, formulated tablets and patches using different polymers such as carbopol 974p, polyvinylpyrrolidone-K 30, sodium deoxycholate, microcrystalline cellulose, and polyvinyl alcohol. An after formulation of batches for
APA, Harvard, Vancouver, ISO, and other styles
3

Blick, Stephanie K. A., and Antona J. Wagstaff. "Fentanyl Buccal Tablet." Drugs 66, no. 18 (2006): 2387–93. http://dx.doi.org/10.2165/00003495-200666180-00013.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Messina, J., M. Darwish, and P. G. Fine. "Fentanyl buccal tablet." Drugs of Today 44, no. 1 (2008): 41. http://dx.doi.org/10.1358/dot.2008.44.1.1178469.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Omer, Mohammed, and S. M. Shahidulla. "Formulation and Evaluation of Mucoadhesive Bilayered Buccal Tablet of Ziprasidone Hydrochloride." Journal of Drug Delivery and Therapeutics 12, no. 5-S (2022): 174–80. http://dx.doi.org/10.22270/jddt.v12i5-s.5757.

Full text
Abstract:
The present project was carried out to formulate and evaluate the mucoadhesive bilayered buccal tablet of Ziprasidone Hcl. Ziprasidone HCl is an antipsychotic agent with half-life of about 2hrs and shows extensive metabolism i.e the drug concentration is < 5% after elimination in the body. The formulations (F1 to F6) were developed which comprises of polymers such as Hydroxypropyl methyl cellulose (HPMC K-15), Polyvinyl pyrollidine (PVP K-30) in various concentrations along with carbopol to achieve the desired characteristics. Mucoadhesive bilayered buccal tablets were fabricated with the a
APA, Harvard, Vancouver, ISO, and other styles
6

Thakare, Eknath B., Prashant S. Malpure, Avish D. Maru, and Yashpal M. More. "Formulation and Evaluation of Mucoadhesive Buccal Tablet of Repaglinide." Journal of Drug Delivery and Therapeutics 9, no. 4-A (2019): 415–24. http://dx.doi.org/10.22270/jddt.v9i4-a.3488.

Full text
Abstract:
The aim of present investigation was formulation and evaluation of mucoadhesive buccal tablet of Repaglinide to study the effect of different polymers on release profile of drug for prolonged release. In this study mucoadhesive buccal tablet were prepared by direct compression method. Various rheological characteristics of the powder bed like bulk density, compressibility index, and angle of repose were evaluated and studied. Mucoadhesive buccal tablets were compressed on a 8 station mini press using 10 mm flat faced punches and were all assessed for weight variation, hardness, thickness, perc
APA, Harvard, Vancouver, ISO, and other styles
7

Nishigandha, Pandurang Gite1* Vinayak Munde2. "Formulation And Evaluation Of Mucoadhesive Buccal Tablet Of Favipiravir." International Journal in Pharmaceutical Sciences 2, no. 8 (2024): 3733–54. https://doi.org/10.5281/zenodo.13371490.

Full text
Abstract:
This research work investigates the formulation and evaluation of mucoadhesive buccal tablets containing Favipiravir, an antiviral medication with proven efficacy against various RNA viruses, including influenza and certain strains of coronaviruses. The objective of this study is to develop a novel drug delivery system that enhances the bioavailability and therapeutic efficacy of Favipiravir through buccal administration, thereby addressing the limitations associated with conventional oral dosage forms. The formulation development phase involves the selection of suitable mucoadhesive polymers
APA, Harvard, Vancouver, ISO, and other styles
8

Sachin, Jagdale, Panbude Aishwarya, and Navasare Priya. "Development, Characterization and Optimization of Mucoadhesive Tablet for Buccal Delivery of Domperidone." Drug Delivery Letters 9, no. 1 (2019): 37–49. http://dx.doi.org/10.2174/2210303108666181108120840.

Full text
Abstract:
Background and Objective: Upon oral administration domeperidone is rapidly absorbed, but subjected to the first pass effect which lowers systemic bioavailability to 15%. Mucoadhesive tablet can remain attached to buccal mucosa and becomes capable of bypassing hepatic first-pass metabolism to improve absorption directly into systemic circulation. The present research work was carried with an aim to develop, evaluate and optimize mucoadhesive tablet containing domperidone (DOME) for buccal delivery using different bio-adhesive polymeric combinations. </P><P> Methods: The buccal table
APA, Harvard, Vancouver, ISO, and other styles
9

Kaundal, Ankaj, Pravin Kumar, Rajendra Awasthi, and Giriraj T. Kulkarni. "Development of Mucoadhesive Buccal Drug Delivery System of Propranolol Hydrochloride Using Aster ericoides Mucilage." Drug Delivery Letters 10, no. 2 (2020): 133–48. http://dx.doi.org/10.2174/2210303109666191010164201.

Full text
Abstract:
Aim: The study was aimed to develop mucoadhesive buccal tablets using Aster ericoides leaves mucilage. Background : Mucilages are naturally occurring high-molecular-weight polyuronides, which have been extensively studied for their application in different pharmaceutical dosage forms. Objective: The objective of the present research was to establish the mucilage isolated from the leaves of Aster ericoides as an excipient for the formulation of the mucoadhesive buccal tablet. Method: The mucilage was isolated from the leaves of Aster ericoides by maceration, precipitated with acetone and charac
APA, Harvard, Vancouver, ISO, and other styles
10

FALAHI, ASA, and DEWI RASHATI. "OPTIMASI FORMULA TABLET BUKAL MUKOADHESIVE GLIBENKLAMID MENGGUNAKAN MATRIKS CMC NA SERTA ASAM OLEAT SEBAGAI ENHANCHER." JURNAL ILMIAH FARMASI AKADEMI FARMASI JEMBER 4, no. 1 (2021): 38–43. http://dx.doi.org/10.53864/jifakfar.v4i1.49.

Full text
Abstract:
Glibenclamide is a sulfonylurea class of antidiabetic drugs that works by stimulating insulin secretion in the pancreas so that it is effective only when the β-cells of the pancreas can still produce. The glibenclamide dosage form that is on the market is a conventional oral tablet which has various disadvantages in terms of pharmacokinetics. Based on this, it is necessary to develop a more effective drug delivery system for glibenclamide in order to avoid first-pass metabolism so as to increase the bioavailability of glibenclamide, namely by making mucoadhesive buccal tablets. This glibenclam
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Buccal tablet"

1

Iyire, Affiong. "Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology." Thesis, Aston University, 2016. http://publications.aston.ac.uk/30165/.

Full text
Abstract:
Buccal drug delivery combines the advantage of enhanced patient acceptance/ compliance of oral delivery, with overcoming drug degradation and poor absorption in the gastro intestinal tract (GIT), especially for large molecule therapeutics, such as insulin. Orally disintegrating tablets (ODTs) that dissolve rapidly in the mouth, are gaining widespread popularity, especially with extreme populations, including children and the elderly. This project unifies the advantages of buccal drug delivery with that of ODTs, with the view to developing a non-invasive delivery system for proteins like insuli
APA, Harvard, Vancouver, ISO, and other styles
2

Al-Ani, Enas Atallah. "Towards a more efficacious treatment for oropharyngeal candidiasis (OPC) : hydrogel-forming tablets for the controlled release delivery of chlorhexidine diacetate." Thesis, University of Wolverhampton, 2018. http://hdl.handle.net/2436/621861.

Full text
Abstract:
Oropharyngeal candidiasis is a localised infection in the oropharynx region caused by Candida species, predominately C. albicans. It is commonly spread among immunocompromised patients and aggravated by hyposalivation or xerostomia. Current treatment is by systemic antifungals, which might be accompanied by gastrointestinal tract disorders, headache, allergic reactions and drug interactions or Candida becoming resistant to them. In the present work, the anti-candida activity of chlorhexidine diacetate (CHD) was tested as the drug of choice, it has no systemic side effects and microorganisms do
APA, Harvard, Vancouver, ISO, and other styles
3

Bouckaert, Stefan. "Ontwikkeling en evaluatie van een buccale bioadhesieve tablet voor lokale therapie /." Gent : Univ., Fac. van de Farmaceut. Wetenschappen, 1994. http://www.gbv.de/dms/bs/toc/211006491.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Park, Calum R. "Mucoadhesive buccal tablets for the delivery of nicotine and Δ9-tetrahydrocannabinol." Thesis, Robert Gordon University, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.408996.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Owens, Tim Sadley. "Development and Evaluation of Extended Release Bioadhesive Sodium Fluoride Tablets." University of Cincinnati / OhioLINK, 2004. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1100715863.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rosa, Gabriela Cauduro da. "Análise da amplitude de abertura bucal e seu enquadramento em tabelas de quantificação do dano odontológico." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/23/23153/tde-04042018-110327/.

Full text
Abstract:
Introdução: A região da face corresponde a parte do corpo mais atingida em casos de traumas. Isso ocorre por ser uma área sem proteção e de localização favorável. Traumas nessa região tem como principais causas acidente de trânsito, quedas ou agressões. A consequência mais prevalente é a fratura na região mandibular. Em decorrência disso, é possível perceber diversos prejuízos, dentre eles a limitação na abertura bucal. No entanto, para que seja definido um dano é necessário que se conheça o padrão de normalidade. O Código Civil brasileiro aponta que todo o dano causado por ato ilícito deve se
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Buccal tablet"

1

Formulation and Evaluation of Antifungal Buccal Tablets. Independently Published, 2020.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Buccal tablet"

1

"Slowly Disintegrating Buccal Mucoadhesive Plain-Tablet (S-DBMP-T) and Buccal Covered-Tablet System (BCTS)." In Modified-Release Drug Delivery Technology. CRC Press, 2002. http://dx.doi.org/10.1201/9780203910337-33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Iga, Katsumi. "Slowly Disintegrating Buccal Mucoadhesive Plain-Tablet (S-DBMP-T) and Buccal Covered- Tablet System (BCTS)." In Drugs and the Pharmaceutical Sciences. Informa Healthcare, 2002. http://dx.doi.org/10.1201/9780203910337.ch30.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Fudala, Paul J., and Anne Cramer Andorn. "Use of Buprenorphine for the Treatment of Opioid Use Disorder." In Substance Use Disorders. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780190920197.003.0009.

Full text
Abstract:
Buprenorphine is a mu-opioid partial agonist that was first developed as a parenteral analgesic and subsequently as a treatment for opioid dependence. In the United States, the first two products approved by the US Food and Drug Administration (in 2002) for the latter indication were buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) tablet formulations for sublingual administration. Since that time, additional products for both sublingual and buccal administration have also been approved, as well as a subcutaneous injection for once-monthly administration for the treatment of moder
APA, Harvard, Vancouver, ISO, and other styles
4

"Polysaccharide-Based Mucoadhesive Buccal Tablets." In Modified-Release Drug Delivery Technology. CRC Press, 2002. http://dx.doi.org/10.1201/9780203910337-36.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Johnston, Thomas, Ashim Mitra, and Hemant Alur. "Polysaccharide-Based Mucoadhesive Buccal Tablets." In Drugs and the Pharmaceutical Sciences. Informa Healthcare, 2002. http://dx.doi.org/10.1201/9780203910337.ch33.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"Table of Contents." In La historia clínica médico-bucal. Editorial Unimagdalena, 2025. https://doi.org/10.2307/jj.30347870.2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

M, Abirami, and Rajesh Kumar N. "PHARMACEUTICAL PREPARATION AND DRUG DELIVERY." In Futuristic Trends in Pharmacy & Nursing Volume 3 Book 4. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bipn4p6ch4.

Full text
Abstract:
Pharmaceutical preparations are medicinal preparations that are used in the treatment of various diseases. various dosage forms are necessary to achieve a predictable therapeutic response to a drug product contained in a formulation. Medicinal preparations are available in various dosage forms such as liquids, tablets, capsules, suppositories, Inhalers, topical dosage forms, drops, injections, patches, and buccal tablets. Drug delivery refers to the approaches, formulations, production techniques, storage systems, and technologies used to transfer a pharmaceutical molecule to its targeted ther
APA, Harvard, Vancouver, ISO, and other styles
8

Shwetha, K., and B. V. Basavaraj. "Optimization of Vanillin Crosslinked Chitosan/Polycarbophil Superporous Hydrogel Hybrids Containing Tablets for Regulated Drug Delivery." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00523.

Full text
Abstract:
Polysaccharides are most sustainable building blocks with improved characteristics for formulation of superporous hydrogels (SPH). Present research work emphasis on development and optimization of tablets comprising vanillin crosslinked chitosan/polycarbophil (CVP) SPH hybrids for regulated drug delivery. The formulation of CVP SPH hybrids were prepared using microwave irradiation with different concentrations of chitosan (polymer), vanillin (crosslinking agent) and polycarbophil (hybrid agent). Resultant formulation was subjected to FTIR, DSC, TGA, SEM and NMR characterization. Prepared CVP h
APA, Harvard, Vancouver, ISO, and other styles
9

Pentu, Narendra, Manikanta Murahari, and G. Narayana Murthy. "Formulation of Candisartan Mucoadhesive Buccal Tablets After Improving the Solubility by Solid Dispersion and Inclusion Complex Methods." In Current Trends in Drug Discovery, Development and Delivery (CTD4-2022). Royal Society of Chemistry, 2023. http://dx.doi.org/10.1039/9781837671090-00427.

Full text
Abstract:
This research work aimed to develop and evaluate the buccal tablets of Candesartan using various Mucoadhesive polymers viz. Hydroxy Propyl Methyl Cellulose (HPMC K4M), Sodium Carboxy methyl cellulose (Sodium CMC), Sodium alginate individually and in combination. Candesartan is an angiotensin II receptor blocker (ARB) used in the treatment of hypertension. It shows the oral bioavailability of 15% due to the first-pass metabolism and has a biological half-life of approximately 9hrs. It is poorly absorbed after oral administration, and having poor solubility and wettability leads to poor dissolut
APA, Harvard, Vancouver, ISO, and other styles
10

Rossi, Thais Regis Aranha. "Mudanças na tabela SIA/SUS e procedimentos coletivos." In Produção social das políticas de saúde bucal no Brasil. EDUFBA, 2018. http://dx.doi.org/10.7476/9788523220228.0006.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Buccal tablet"

1

Ranganathan, Venkatalakshmi, Yeo Pei Xia, Gooi Mei Seong, Gan Li Ting, and Ravi Sheshala. "Metoprolol Tartrate Delivery From Mucoadhesive Buccal Tablet." In Annual International Conference on Pharmacology and Pharmaceutical Sciences. Global Science & Technology Forum (GSTF), 2014. http://dx.doi.org/10.5176/2345-783x_pharma14.51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kurcubic, Ivana, and Jelena Đuriš. "Influence of experimental model, active substance and polymer type on mucoadhesive properties of buccal tablets." In II. Symposium of Young Researchers on Pharmaceutical Technology,Biotechnology and Regulatory Science. Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 2020. http://dx.doi.org/10.14232/syrptbrs.2020.op6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sulukdjian, A., D. Nguyen, V. Luciani, A. Chanlon, and N. Moreau. "Intérêt de l’indométacine comme traitement d’épreuve des céphalées hémi-faciales : aspects cliniques et pharmacologiques." In 66ème Congrès de la SFCO. EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603015.

Full text
Abstract:
Intérêt de l’indométacine comme traitement d’épreuve des céphalées hémi-faciales : aspects cliniques et pharmacologiques Arek SULUKDJIAN1, Diane NGUYEN2, Vanina LUCIANI3, Audrey CHANLON2, Nathan MOREAU4,5 1- Etudiant en 5ème année de chirurgie dentaire, Faculté de Chirurgie dentaire, Université Paris Descartes 2 - Praticien attaché, consultation de diagnostic et traitement des douleurs chroniques orofaciales, service de médecine bucco- dentaire, Hôpital Bretonneau, AP-HP, Paris 3 - Etudiante en 6ème année de chirurgie dentaire, Faculté de Chirurgie dentaire, Université Paris Descartes 4 - Resp
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!